53
Views
6
CrossRef citations to date
0
Altmetric
Original Research

CpG oligodeoxyribonucleotide 7909 enhances radiosensitivity via downregulating Oct-4 expression in radioresistant lung cancer cells

, , , , &
Pages 1443-1449 | Published online: 12 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (5)

Johannes Routila, Karri Suvila, Reidar Grénman, Ilmo Leivo, Jukka Westermarck & Sami Ventelä. (2021) Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma. BMC Cancer 21:1.
Crossref
Asunción Espinosa-Sánchez, Elisa Suárez-Martínez, Laura Sánchez-Díaz & Amancio Carnero. (2020) Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness. Frontiers in Oncology 10.
Crossref
Marc J. Braunstein, John Kucharczyk & Sylvia Adams. (2018) Targeting Toll-Like Receptors for Cancer Therapy. Targeted Oncology 13:5, pages 583-598.
Crossref
Sujuan Yuan, Tiankui Qiao, Xuan Li, Xibing Zhuang, Wei Chen, Xue Chen & Qi Zhang. (2018) Toll-like receptor 9 activation by CpG oligodeoxynucleotide�7909 enhances the radiosensitivity of A549 lung cancer cells via the p53 signaling pathway. Oncology Letters.
Crossref
Jason R. Baird, Arta M. Monjazeb, Omid Shah, Heather McGee, William J. Murphy, Marka R. Crittenden & Michael J. Gough. (2017) Stimulating Innate Immunity to Enhance Radiation Therapy–Induced Tumor Control. International Journal of Radiation Oncology*Biology*Physics 99:2, pages 362-373.
Crossref